跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brezofree 125 Synchrobreathe SB - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brezofree 125 Synchrobreathe SB
Approved
STANDARD
Brezofree 125 Synchrobreathe SB
Cipla Ltd. (Unit II)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fc5b2db9d887342e
Company
Cipla Ltd. (Unit II)
Type
Standard
Approval Details
Approval Id
fc5b2db9d887342e
Drug Approval Philippines Name
Brezofree 125 Synchrobreathe SB
Product Name
Brezofree 125 Synchrobreathe SB
Registration Number
DRP-11325
Brand Name
Brezofree 125 Synchrobreathe SB
Generic Name
Salmeterol (as xinafoate) + Fluticasone Propionate
Dosage Form
Metered Dose Inhaler (Suspension)
Dosage Strength
25 mcg/125 mcg
Manufacturer
Cipla Ltd. (Unit II)
Importer
RV Group Phil. Branch
Distributor
RV Group Phil. Branch
Issuance Date
24 June 2024
Expiry Date
02 March 2027
Pharmacologic Category
Anti-asthma (Adrenergic/Corticosteroid)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fc5b2db9d887342e
Type
Standard
Back to Philippines FDA Approvals